TNF and myeloid sarcoma: It plays a complex and multi-layered role in the immunopathogenesis of MS, as evidenced by findings from both preclinical models and human studies—including the unexpected worsening of disease observed in a clinical trial, non-selectively targeting TNF inhibition [38,39,40].